Competitors of Ajanta Pharma Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn Ltd | 3,728 Cr. | 342 | 390/108 | 70.7 | 20.5 | 0.19 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 56.4 Cr. | 76.0 | 94.9/25.8 | 21.6 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 27.8 Cr. | 19.0 | 19.5/8.35 | 36.1 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
| Godavari Drugs Ltd | 92.1 Cr. | 122 | 155/87.0 | 13.8 | 55.4 | 0.00 % | 12.7 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 13,287 Cr. | 1,085 | 1,335/627 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 434 Cr. | 19.1 | 29.0/13.2 | 25.1 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 8.70 Cr. | 18.0 | 28.5/15.0 | 174 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 370 Cr. | 788 | 1,054/650 | 21.0 | 278 | 0.09 % | 17.1 % | 14.3 % | 10.0 |
| Fervent Synergies Ltd | 53.7 Cr. | 17.9 | 27.8/14.6 | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 1,197 Cr. | 407 | 414/145 | 146 | 98.6 | 0.31 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 6.57 Cr. | 31.2 | 43.8/23.6 | 131 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 19.4 Cr. | 7.80 | 19.4/7.17 | 43.2 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 117 Cr. | 147 | 184/110 | 50.6 | 0.00 % | 6.03 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 152 Cr. | 2.18 | 3.10/0.98 | 205 | 3.80 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 16.2 Cr. | 6.73 | 14.5/6.40 | 14.8 | 15.6 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 15.6 Cr. | 15.5 | 25.8/14.4 | 18.8 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 287 Cr. | 804 | 999/345 | 12.4 | 570 | 0.25 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 37.3 Cr. | 37.3 | 61.5/30.6 | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 | |
| Colinz Laboratories Ltd | 27.9 Cr. | 61.0 | 84.4/36.0 | 50.7 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 12.0 Cr. | 4.82 | 26.5/4.12 | 48.2 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 13.7 Cr. | 91.1 | 94.7/40.4 | 10.9 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 9.02 Cr. | 16.5 | 17.4/4.09 | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 | |
| Chandra Bhagat Pharma Ltd | 52.0 Cr. | 68.9 | 160/63.0 | 32.9 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 6.51 Cr. | 21.7 | 27.8/14.6 | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 109 Cr. | 25.3 | 43.9/22.2 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 17.4 Cr. | 34.4 | 46.0/21.8 | 51.3 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 210 Cr. | 365 | 418/175 | 21.6 | 110 | 1.23 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 29.8 Cr. | 50.5 | 50.8/4.68 | 76.3 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 74,051 Cr. | 1,264 | 1,593/958 | 20.3 | 527 | 0.36 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 139 Cr. | 223 | 307/112 | 22.5 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 1,062 Cr. | 212 | 265/140 | 18.0 | 60.5 | 1.18 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 62.7 Cr. | 48.0 | 86.1/43.0 | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 9,253 Cr. | 2,260 | 2,320/1,004 | 99.1 | 294 | 0.13 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 7.00 Cr. | 1.06 | 1.20/0.55 | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 448 Cr. | 58.4 | 77.7/37.5 | 33.6 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 13.2 Cr. | 22.6 | 29.0/11.9 | 2.70 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 129 Cr. | 76.8 | 86.4/40.2 | 196 | 18.5 | 0.00 % | 3.27 % | 2.52 % | 10.0 |
| Abbott India Ltd | 60,437 Cr. | 28,441 | 30,521/21,983 | 47.0 | 1,657 | 1.44 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,954 Cr. | 658 | 722/381 | 26.1 | 205 | 0.46 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 176 Cr. | 63.1 | 75.8/37.0 | 25.6 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
| Zota Health Care Ltd | 1,708 Cr. | 623 | 725/440 | 58.0 | 0.16 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 22,785 Cr. | 1,404 | 1,467/326 | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 894 Cr. | 272 | 291/111 | 32.4 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 0.66 | 0.00 % | 11.0 % | 268 % | 2.00 | |
| Venus Remedies Ltd | 426 Cr. | 319 | 430/280 | 19.3 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 5,889 Cr. | 836 | 950/401 | 118 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 2,158 Cr. | 1,527 | 1,923/1,232 | 33.4 | 735 | 0.65 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,13,817 Cr. | 3,363 | 3,591/2,025 | 65.4 | 222 | 0.83 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,700 Cr. | 293 | 317/168 | 51.0 | 44.8 | 0.17 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 2,074 Cr. | 22.1 | 27.9/10.6 | 65.3 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 32,861 Cr. | 1,291 | 1,360/585 | 135 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,945 Cr. | 135 | 169/74.5 | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,31,892 Cr. | 1,800 | 1,960/1,209 | 38.5 | 288 | 0.75 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 3,621 Cr. | 828 | 886/292 | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 2,206 Cr. | 261 | 398/113 | 37.6 | 70.6 | 0.15 % | 11.2 % | 9.27 % | 1.00 |
| SMS Lifesciences India Ltd | 353 Cr. | 1,169 | 1,750/487 | 17.4 | 621 | 0.13 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 8,711 Cr. | 891 | 960/313 | 152 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 5,079 Cr. | 203 | 241/91.8 | 239 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 14,637 Cr. | 6,356 | 7,600/4,606 | 34.7 | 298 | 2.63 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,671 Cr. | 2,220 | 2,977/1,290 | 42.2 | 229 | 0.72 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,780 Cr. | 5,289 | 5,836/4,637 | 38.7 | 324 | 1.13 % | 45.0 % | 33.5 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 237 Cr. | 67.2 | 87.5/31.9 | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 24,568 Cr. | 5,370 | 6,453/3,950 | 40.1 | 820 | 0.65 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 343 Cr. | 279 | 348/190 | 18.8 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,734 Cr. | 446 | 488/112 | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 8,530 Cr. | 1,682 | 1,749/557 | 71.7 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 22,000 Cr. | 17,148 | 17,300/4,926 | 83.3 | 1,087 | 0.08 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 766 Cr. | 34.2 | 56.5/26.2 | 71.4 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 25,606 Cr. | 1,430 | 1,639/752 | 13.2 | 399 | 0.66 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,713 Cr. | 86.0 | 101/38.6 | 35.9 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 15,836 Cr. | 349 | 359/126 | 45.8 | 50.3 | 0.17 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 190 Cr. | 120 | 145/85.2 | 20.2 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 585 Cr. | 164 | 173/97.9 | 185 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
| Lupin Ltd | 94,964 Cr. | 2,082 | 2,312/1,200 | 36.2 | 343 | 0.38 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,529 Cr. | 763 | 814/498 | 15.8 | 319 | 0.24 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 31,309 Cr. | 581 | 588/359 | 133 | 79.2 | 0.14 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 933 Cr. | 900 | 961/356 | 27.1 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 230 Cr. | 107 | 129/60.0 | 60.4 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,043 Cr. | 216 | 370/198 | 19.7 | 103 | 1.39 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 521 Cr. | 324 | 470/298 | 37.1 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
| Jubilant Pharmova Ltd | 19,541 Cr. | 1,227 | 1,310/451 | 68.7 | 373 | 0.41 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 27,916 Cr. | 1,796 | 2,030/1,400 | 45.7 | 207 | 0.68 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,893 Cr. | 714 | 820/270 | 70.8 | 74.4 | 0.70 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 38,125 Cr. | 1,503 | 1,709/1,041 | 61.2 | 264 | 0.27 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,313 Cr. | 394 | 538/331 | 23.1 | 283 | 1.27 % | 12.3 % | 8.68 % | 10.0 |
| Indoco Remedies Ltd | 2,954 Cr. | 320 | 417/286 | 132 | 118 | 0.47 % | 10.4 % | 8.33 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 44,004 Cr. | 1,559 | 1,831/767 | 299 | 0.16 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 41,033 Cr. | 2,422 | 3,088/1,661 | 51.2 | 98.7 | 1.32 % | 51.3 % | 37.3 % | 10.0 |
| Dr Reddys Laboratories Ltd | 1,02,170 Cr. | 1,224 | 1,421/1,074 | 19.1 | 369 | 0.65 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,868 Cr. | 247 | 283/133 | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,23,880 Cr. | 1,534 | 1,702/1,192 | 26.9 | 351 | 0.85 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 17,577 Cr. | 2,312 | 2,354/1,178 | 35.6 | 334 | 0.22 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 358 Cr. | 136 | 186/72.5 | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,725 Cr. | 164 | 172/92.2 | 19.5 | 96.0 | 0.31 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 108 Cr. | 66.4 | 92.0/50.8 | 204 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 44,884 Cr. | 374 | 396/237 | 31.1 | 175 | 0.13 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 2,156 Cr. | 2,242 | 2,326/1,060 | 52.6 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 196 Cr. | 123 | 158/89.0 | 25.7 | 43.2 | 0.98 % | 12.1 % | 11.0 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 193 Cr. | 81.4 | 113/73.2 | 250 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 16,444 Cr. | 6,578 | 8,140/4,050 | 128 | 272 | 0.36 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,167 Cr. | 750 | 863/556 | 45.6 | 103 | 0.61 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 246 Cr. | 117 | 145/69.9 | 11.8 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 67,403 Cr. | 5,637 | 6,440/4,407 | 31.0 | 961 | 0.71 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 21,608 Cr. | 1,099 | 1,304/745 | 34.0 | 249 | 1.00 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 791 Cr. | 1,386 | 1,754/911 | 11.6 | 724 | 0.83 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 37,070 Cr. | 2,968 | 3,486/1,850 | 42.4 | 294 | 1.21 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 4,174 Cr. | 373 | 571/326 | 28.5 | 120 | 1.37 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,249 Cr. | 462 | 635/430 | 34.0 | 126 | 0.22 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 19,818.95 Cr | 1,257.77 | 59.13 | 184.91 | 0.31% | 16.36% | 16.88% | 6.61 |
